Cholinergic Control of Inflammation, Metabolic Dysfunction, and Cognitive Impairment in Obesity-Associated Disorders: Mechanisms and Novel Therapeutic Opportunities.

MLA

Chang, Eric H., et al. “Cholinergic Control of Inflammation, Metabolic Dysfunction, and Cognitive Impairment in Obesity-Associated Disorders: Mechanisms and Novel Therapeutic Opportunities.” Frontiers in Neuroscience, Apr. 2019, p. N.PAG. EBSCOhost, https://doi.org/10.3389/fnins.2019.00263.

APA

Chang, E. H., Chavan, S. S., & Pavlov, V. A. (2019). Cholinergic Control of Inflammation, Metabolic Dysfunction, and Cognitive Impairment in Obesity-Associated Disorders: Mechanisms and Novel Therapeutic Opportunities. Frontiers in Neuroscience, N.PAG. https://doi.org/10.3389/fnins.2019.00263

Chicago

Chang, Eric H., Sangeeta S. Chavan, and Valentin A. Pavlov. 2019. “Cholinergic Control of Inflammation, Metabolic Dysfunction, and Cognitive Impairment in Obesity-Associated Disorders: Mechanisms and Novel Therapeutic Opportunities.” Frontiers in Neuroscience, April, N.PAG. doi:10.3389/fnins.2019.00263.